Three out of four women will have a vaginal yeast infection in their lifetime and an estimated 140 million women worldwide suffer recurrent infections.1 Recurrent infections can have a significantly detrimental impact on quality of life, and because resistance against existing treatments is on the rise, women are in dire need of viable treatment alternatives.… Read More »
This article was previously published January 1, 2019, and has been updated with new information. Vitamin D deficiency is incredibly common around the world, but many mistakenly believe they aren’t at risk because they consume vitamin D-fortified foods, such as milk. However, few foods have therapeutic levels of vitamin D naturally, and even fortified foods… Read More »
Vitamin D deficiency strongly exaggerates the craving for and effects of opioids, potentially increasing the risk for dependence and addiction, according to a new study led by researchers at Massachusetts General Hospital (MGH). These findings, published in Science Advances, suggest that addressing the common problem of vitamin D deficiency with inexpensive supplements could play a… Read More »
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More »
FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »